As of Jun 23, 2026, CME's PEG ratio of 1.12 reflects its valuation relative to its growth. This value reflects a P/E ratio of 20.53 measured against EPS growth of 18.4%. When compared to the trailing four-quarter average of 1.99, CME's PEG ratio shows a 44% decrease.
Cme Group's ten years historical PEG ratio has an average of 3.05. Compared to historical data, CME's 1.12 PE to growth ratio represents a decline of 63%. CME reached its maximum PEG ratio of 15.13 during the Dec 2022 quarter over the past ten years. The Sep 2018 quarter had the bottom reading at 0.06, indicating the most optimal growth-adjusted valuation.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | 1.59 | 24.43 | 15.4% |
| 2024 | 2.61 | 23.97 | 9.2% |
| 2023 | 1.21 | 23.74 | 19.7% |
| 2022 | 15.13 | 22.69 | 1.5% |
| 2021 | 1.3 | 31.3 | 24.1% |
| 2020 | N/A | 30.96 | -0.8% |
| 2019 | 9.67 | 33.85 | 3.5% |
| 2018 | N/A | 32.83 | -52.3% |
| 2017 | 0.07 | 12.17 | 163.7% |
| 2016 | 1.12 | 25.35 | 22.6% |
| 2015 | 2.42 | 24.42 | 10.1% |
| 2014 | 1.8 | 26.31 | 14.6% |
| 2013 | 3.14 | 26.69 | 8.5% |
| 2012 | N/A | 18.7 | -50.3% |
| 2011 | 0.1 | 8.94 | 89.9% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 1.36 | 25.03 | 18.4% |
| Dec 2025 | 1.59 | 24.43 | 15.4% |
| Sep 2025 | 3.11 | 26.16 | 8.4% |
| Jun 2025 | 1.9 | 26.63 | 14% |
| Mar 2025 | 1.99 | 26.61 | 13.4% |
| Dec 2024 | 2.61 | 23.97 | 9.2% |
| Sep 2024 | 1.7 | 23.15 | 13.6% |
| Jun 2024 | 2.02 | 21.65 | 10.7% |
| Mar 2024 | 2.13 | 24.49 | 11.5% |
| Dec 2023 | 1.21 | 23.74 | 19.7% |
| Sep 2023 | 1.67 | 23.86 | 14.3% |
| Jun 2023 | 13.29 | 22.6 | 1.7% |
| Mar 2023 | 8.38 | 24.3 | 2.9% |
| Dec 2022 | 15.13 | 22.69 | 1.5% |
| Sep 2022 | 2.98 | 24.13 | 8.1% |
When comparing to historical values, CME's PEG ratio is below the 3, 5 and 10-year averages.
With a PEG of 1.12, CME is above the Financial Services sector, the industry and its peers average. Compared to its Financial Services sector average of 0.47, Cme Group's PEG is 138% higher.
Compared to its peers, CME has a PEG ratio under stock MSCI, while above ICE's and NDAQ's. At 1.12, Cme Group's PEG ratio stands higher than the peer group average of 0.74.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| CBOE Cboe Global Markets Inc | 0.41 | $26.94B |
| ICE Intercontinental Exchange Inc | 0.46 | $75.21B |
| NDAQ Nasdaq Inc | 0.48 | $46.65B |
| CME Cme Group Inc | 1.12 | $87.78B |
| MSCI MSCI Inc | 1.62 | $42.33B |
CME shows a PEG ratio of 1.12, per Jun 23, 2026 data.
CME's 3-year PEG ratio average stands at 2.88.
CME's 5-year PEG ratio average stands at 3.46.
The Dec 2022 quarter marked the ten years high at 15.13 for CME's PEG ratio.
Currently, CME's PEG ratio stands 63% lower than its 10-year historical average.
To calculate the PEG ratio, take the company's PE ratio and divide by its EPS growth (YoY TTM). As of Jun 23, 2026, Cme Group has a P/E ratio of 20.53. Earnings grew at 18.4% over the TTM period ending Mar 2026. Applying the formula, this produces a price to earnings growth ratio of 1.12. PEG RATIO(1.12) = PE RATIO(20.53) / EPS GROWTH(18.4%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.